Reply to comment on: "Advantages of bevacizumab for aggressive posterior retinopathy of prematurity"

被引：0
|
作者：
Schechet, Sidney A. [1 ]
Rodriguez, Sarah [1 ]
Shapiro, Michael [2 ]
Blair, Michael [1 ,2 ]
机构：
[1] Univ Chicago, Dept Ophthalmol & Visual Sci, 5841 S Maryland Ave,MC2114, Chicago, IL 60637 USA
[2] Retina Consultants Ltd, 2454 E Dempster St,Suite 400, Des Plaines, IL USA
来源：
TAIWAN JOURNAL OF OPHTHALMOLOGY | 2019年 / 9卷 / 02期
关键词：
D O I：
10.4103/tjo.tjo_10_19
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [1] Comment on "bevacizumab or laser for aggressive posterior retinopathy of prematurity"
    Samanta, Ramanuj
    [J]. TAIWAN JOURNAL OF OPHTHALMOLOGY, 2019, 9 (02) : 134 - 135
  • [2] Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity
    Travassos, Antonio
    Teixeira, Susana
    Ferreira, Pinto
    Regadas, Isaura
    Travassos, Ana Sofia
    Esteves Esperancinha, Florindo
    Prieto, Isabel
    Pires, Graca
    Van Velze, Robert
    Valido, A.
    do Ceu Machado, Maria
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING, 2007, 38 (03) : 233 - 237
  • [3] Bevacizumab or laser for aggressive posterior retinopathy of prematurity
    Blair, Michael
    Gonzalez, Jose Maria Garcia
    Snyder, Laura
    Schechet, Sidney
    Greenwald, Mark
    Shapiro, Michael
    Rodriguez, Sarah Hilkert
    [J]. TAIWAN JOURNAL OF OPHTHALMOLOGY, 2018, 8 (04) : 243 - 248
  • [4] Rescue Intravitreal Bevacizumab (Avastin) for Aggressive Posterior Retinopathy of Prematurity
    Qureshi, Farhan
    Dewhurst, Christopher
    Yoxall, C. W.
    Clark, David
    [J]. SEMINARS IN OPHTHALMOLOGY, 2011, 26 (02) : 55 - 58
  • [5] Intravitreal bevacizumab injection in aggressive posterior retinopathy of prematurity compared with type I retinopathy of prematurity
    Amir Eftekhari Milani
    Narges Hassanpoor
    Mohammadreza Mousavi Mirkala
    Arash Taheri
    Ali Golizade
    Mohamad Reza Niyousha
    [J]. International Ophthalmology, 2020, 40 : 477 - 482
  • [6] Intravitreal bevacizumab injection in aggressive posterior retinopathy of prematurity compared with type I retinopathy of prematurity
    Milani, Amir Eftekhari
    Hassanpoor, Narges
    Mirkala, Mohammadreza Mousavi
    Taheri, Arash
    Golizade, Ali
    Niyousha, Mohamad Reza
    [J]. INTERNATIONAL OPHTHALMOLOGY, 2020, 40 (02) : 477 - 482
  • [7] The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity
    Comez, Aysegul
    Karakucuk, Yalcin
    Ozmen, Mehmet Cuneyt
    Celemler, Pelin
    Saygili, Oguzhan
    [J]. EYE, 2021, 35 (12) : 3302 - 3310
  • [8] The results of intravitreal bevacizumab monotherapy for treating aggressive posterior retinopathy of prematurity and Type 1 retinopathy of prematurity
    Ayşegül Çömez
    Yalçın Karaküçük
    Mehmet Cüneyt Özmen
    Pelin Çelemler
    Oğuzhan Saygılı
    [J]. Eye, 2021, 35 : 3302 - 3310
  • [9] Foveal Development After Use of Bevacizumab for Aggressive Posterior Retinopathy of Prematurity
    Tiryaki, Semra
    Garcia-Gonzalez, Jose M.
    Zhang, David L.
    Shapiro, Michael J.
    Blair, Michael P.
    [J]. OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2019, 50 (06): : E185 - E187
  • [10] Aggressive Posterior Retinopathy Of Prematurity: Functional Outcomes Following Intravitreal Bevacizumab
    Rubino, Shaina
    Quiram, Polly
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
12345